117 related articles for article (PubMed ID: 38623750)
1. Naturally developed HPV16 antibodies and risk of newly detected cervical HPV infection outcomes.
Trevisan A; Candeias JMG; Thomann P; Villa LL; Franco EL; Trottier H
J Med Virol; 2024 Apr; 96(4):e29608. PubMed ID: 38623750
[TBL] [Abstract][Full Text] [Related]
2. Correlation between cervical HPV DNA detection and HPV16 seroreactivity measured with L1-only and L1+L2 viral capsid antigens.
Trevisan A; Candeias JMG; Thomann P; Villa LL; Franco EL; Trottier H; The Ludwig-McGill Study Group
J Med Microbiol; 2020 Jul; 69(7):960-970. PubMed ID: 32510304
[No Abstract] [Full Text] [Related]
3. Risk of newly detected infections and cervical abnormalities in adult women seropositive or seronegative for naturally acquired HPV-16/18 antibodies.
Rosillon D; Baril L; Del Rosario-Raymundo MR; Wheeler CM; Skinner SR; Garland SM; Salmeron J; Lazcano-Ponce E; Vallejos CS; Stoney T; Ter Harmsel B; Lim TYK; Quek SC; Minkina G; McNeil SA; Bouchard C; Fong KL; Money D; Ilancheran A; Savicheva A; Cruickshank M; Chatterjee A; Fiander A; Martens M; Bozonnat MC; Struyf F; Dubin G; Castellsagué X
Cancer Med; 2019 Aug; 8(10):4938-4953. PubMed ID: 31273942
[TBL] [Abstract][Full Text] [Related]
4. A virus-like particle enzyme-linked immunosorbent assay detects serum antibodies in a majority of women infected with human papillomavirus type 16.
Kirnbauer R; Hubbert NL; Wheeler CM; Becker TM; Lowy DR; Schiller JT
J Natl Cancer Inst; 1994 Apr; 86(7):494-9. PubMed ID: 8133532
[TBL] [Abstract][Full Text] [Related]
5. Epidemiological study of anti-HPV16/18 seropositivity and subsequent risk of HPV16 and -18 infections.
Safaeian M; Porras C; Schiffman M; Rodriguez AC; Wacholder S; Gonzalez P; Quint W; van Doorn LJ; Sherman ME; Xhenseval V; Herrero R; Hildesheim A;
J Natl Cancer Inst; 2010 Nov; 102(21):1653-62. PubMed ID: 20944077
[TBL] [Abstract][Full Text] [Related]
6. Effect of naturally acquired type-specific serum antibodies against human papillomavirus type 16 infection.
Triglav T; Artemchuk H; Oštrbenk A; Elfström KM; Faust H; Poljak M; Dillner J
J Clin Virol; 2017 May; 90():64-69. PubMed ID: 28363164
[TBL] [Abstract][Full Text] [Related]
7. [Distribution of serum antibodies against human papillomavirus 16 and 18 among high-risk women to cervical cancer].
Fei M; Li J; Du J; You J; Zhang S; He W; Kang L; Zhao F; Qiao Y; Si Y; Fan X; Chen W
Zhonghua Liu Xing Bing Xue Za Zhi; 2014 May; 35(5):514-8. PubMed ID: 25059358
[TBL] [Abstract][Full Text] [Related]
8. Contribution of Surface-Exposed Loops on the HPV16 Capsid to Antigenic Domains Recognized by Vaccine or Natural Infection Induced Neutralizing Antibodies.
Godi A; Vaghadia S; Cocuzza C; Miller E; Beddows S
Microbiol Spectr; 2022 Jun; 10(3):e0077922. PubMed ID: 35475682
[TBL] [Abstract][Full Text] [Related]
9. Glutathione S-transferase L1 multiplex serology as a measure of cumulative infection with human papillomavirus.
Robbins HA; Li Y; Porras C; Pawlita M; Ghosh A; Rodriguez AC; Schiffman M; Wacholder S; Kemp TJ; Gonzalez P; Schiller J; Lowy D; Esser M; Matys K; Quint W; van Doorn LJ; Herrero R; Pinto LA; Hildesheim A; Waterboer T; Safaeian M
BMC Infect Dis; 2014 Mar; 14():120. PubMed ID: 24588945
[TBL] [Abstract][Full Text] [Related]
10. Redetection of cervical human papillomavirus type 16 (HPV16) in women with a history of HPV16.
Moscicki AB; Ma Y; Farhat S; Darragh TM; Pawlita M; Galloway DA; Shiboski S
J Infect Dis; 2013 Aug; 208(3):403-12. PubMed ID: 23599313
[TBL] [Abstract][Full Text] [Related]
11. Detection of Circulating HPV16 DNA as a Biomarker for Cervical Cancer by a Bead-Based HPV Genotyping Assay.
Galati L; Combes JD; Le Calvez-Kelm F; McKay-Chopin S; Forey N; Ratel M; McKay J; Waterboer T; Schroeder L; Clifford G; Tommasino M; Gheit T
Microbiol Spectr; 2022 Apr; 10(2):e0148021. PubMed ID: 35225653
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of the polyclonal ELISA HPV serology assay as a biomarker for human papillomavirus exposure.
Coseo SE; Porras C; Dodd LE; Hildesheim A; Rodriguez AC; Schiffman M; Herrero R; Wacholder S; Gonzalez P; Sherman ME; Jimenez S; Solomon D; Bougelet C; van Doorn LJ; Quint W; Safaeian M;
Sex Transm Dis; 2011 Oct; 38(10):976-82. PubMed ID: 21934576
[TBL] [Abstract][Full Text] [Related]
13. Seroprevalence and correlates of human papillomavirus 16/18 seropositivity among young women in Costa Rica.
Coseo S; Porras C; Hildesheim A; Rodriguez AC; Schiffman M; Herrero R; Wacholder S; Gonzalez P; Wang SS; Sherman ME; Jimenez S; Solomon D; Bougelet C; van Doorn LJ; Quint W; Safaeian M;
Sex Transm Dis; 2010 Nov; 37(11):706-14. PubMed ID: 20661178
[TBL] [Abstract][Full Text] [Related]
14. HPV-specific antibodies in female genital tract secretions captured via first-void urine retain their neutralizing capacity.
Téblick L; Lipovac M; Molenberghs F; Delputte P; De Vos WH; Vorsters A
Hum Vaccin Immunother; 2024 Dec; 20(1):2330168. PubMed ID: 38567541
[TBL] [Abstract][Full Text] [Related]
15. HPV16 seropositivity and subsequent HPV16 infection risk in a naturally infected population: comparison of serological assays.
Lin SW; Ghosh A; Porras C; Markt SC; Rodriguez AC; Schiffman M; Wacholder S; Kemp TJ; Pinto LA; Gonzalez P; Wentzensen N; Esser MT; Matys K; Meuree A; Quint W; van Doorn LJ; Herrero R; Hildesheim A; Safaeian M;
PLoS One; 2013; 8(1):e53067. PubMed ID: 23301022
[TBL] [Abstract][Full Text] [Related]
16. Comprehensive Assessment of the Antigenic Impact of Human Papillomavirus Lineage Variation on Recognition by Neutralizing Monoclonal Antibodies Raised against Lineage A Major Capsid Proteins of Vaccine-Related Genotypes.
Godi A; Boampong D; Elegunde B; Panwar K; Fleury M; Li S; Zhao Q; Xia N; Christensen ND; Beddows S
J Virol; 2020 Nov; 94(24):. PubMed ID: 32967963
[TBL] [Abstract][Full Text] [Related]
17. HPV Serum Antibodies as Predictors of Survival and Disease Progression in Patients with HPV-Positive Squamous Cell Carcinoma of the Oropharynx.
Dahlstrom KR; Anderson KS; Cheng JN; Chowell D; Li G; Posner M; Sturgis EM
Clin Cancer Res; 2015 Jun; 21(12):2861-9. PubMed ID: 26078432
[TBL] [Abstract][Full Text] [Related]
18. Prognostic Implication of Persistent Human Papillomavirus Type 16 DNA Detection in Oral Rinses for Human Papillomavirus-Related Oropharyngeal Carcinoma.
Rettig EM; Wentz A; Posner MR; Gross ND; Haddad RI; Gillison ML; Fakhry C; Quon H; Sikora AG; Stott WJ; Lorch JH; Gourin CG; Guo Y; Xiao W; Miles BA; Richmon JD; Andersen PE; Misiukiewicz KJ; Chung CH; Gerber JE; Rajan SD; D'Souza G
JAMA Oncol; 2015 Oct; 1(7):907-15. PubMed ID: 26226294
[TBL] [Abstract][Full Text] [Related]
19. Comparison of HPV neutralizing and IgG antibodies in unvaccinated female adolescents.
Yao X; Chu K; Zhao J; Hu Y; Lin Z; Lin B; Chen Q; Li Y; Zhang Q; Fang M; Huang S; Wang Y; Su Y; Wu T; Zhang J; Xia N
Future Microbiol; 2022 Oct; 17():1207-1215. PubMed ID: 35905119
[No Abstract] [Full Text] [Related]
20. Human papillomavirus 16 E6 antibodies are sensitive for human papillomavirus-driven oropharyngeal cancer and are associated with recurrence.
Lang Kuhs KA; Kreimer AR; Trivedi S; Holzinger D; Pawlita M; Pfeiffer RM; Gibson SP; Schmitt NC; Hildesheim A; Waterboer T; Ferris RL
Cancer; 2017 Nov; 123(22):4382-4390. PubMed ID: 28950407
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
